Back to 
Mariner, LLC
Mariner, LLC
ADPT
Showing 0 of 5 quarters
Position history for Mariner, LLC's holdings in Adaptive Biotechnologies Corporation
No. Mariner exited its ADPT (Adaptive Biotechnologies) position in Q1 2024. Its Q4 2023 13F listed 10,599 shares worth $51,935. Mariner first reported ADPT in Q4 2022 and held it in 3 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.